^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Lymphoma

Related cancers:
13h
New P3 trial
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • CD20 (Membrane Spanning 4-Domains A1)
|
CD20 positive
|
doxorubicin hydrochloride • cyclophosphamide
17h
Trial suspension
|
Rituxan (rituximab) • Gazyva (obinutuzumab) • Brukinsa (zanubrutinib) • Tazverik (tazemetostat)
18h
U96-CAR-T-Cells For R/R B-ALL (clinicaltrials.gov)
P1, N=30, Recruiting, The First Affiliated Hospital of Soochow University
New P1 trial
|
CD20 negative
21h
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study (clinicaltrials.gov)
P=N/A, N=30, Completed, Ohio State University Comprehensive Cancer Center | Active, not recruiting --> Completed
Trial completion
23h
New P1 trial
|
Venclexta (venetoclax) • bortezomib • dexamethasone • Darzalex Faspro (daratumumab and hyaluronidase-fihj)
1d
Primary Synovial Sarcoma of the Breast Initially Mimicking Dermatofibrosarcoma Protuberans: A Case Report. (PubMed, Eur J Breast Health)
Surgical margins were negative, and one-year follow-up showed that the patient remained disease-free. This case highlights the importance of immunohistochemistry and molecular testing for accurate diagnosis and appropriate management.
Journal
|
BCL2 (B-cell CLL/lymphoma 2) • CD34 (CD34 molecule) • SSX1 (SSX Family Member 1)
1d
Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell Lymphoma. (PubMed, Phytother Res)
Synergistic effects with bortezomib (BTZ) were analyzed...SNG exerts potent anticancer effects in CTCL by inducing ROS-dependent mitochondrial apoptosis and inhibiting the PI3K/AKT/GSK3 signaling pathway. Its synergy with BTZ and computational validation of AKT/Bcl-2 targeting underscore its potential as a novel therapeutic candidate for CTCL, warranting further preclinical investigation.
Journal • PARP Biomarker • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • MCL1 (Myeloid cell leukemia 1) • BAX (BCL2-associated X protein) • CASP9 (Caspase 9) • XIAP (X-Linked Inhibitor Of Apoptosis)
|
bortezomib
1d
CAR T-cells in hematologic malignancies: Advances, challenges, and future directions. (PubMed, iScience)
Integration of artificial intelligence and point-of-care manufacturing may further streamline production and patient selection. Continued innovation will determine the long-term impact of CAR T-cell therapy as a scalable pillar of precision hematologic oncology.
Review • Journal
|
TNFRSF17 (TNF Receptor Superfamily Member 17)
1d
Confronting Upside-Down Video-Assisted Thoracic Surgery for Anterior Mediastinal Leiomyoma. (PubMed, Surg Case Rep)
Primary leiomyoma of the anterior mediastinum is extremely rare. Because primary mediastinal leiomyomas have nonspecific imaging features, distinguishing them from other anterior mediastinal tumors is challenging; thus, surgical resection is required for both diagnosis and treatment. Compared with the conventional look-up method, the confronting upside-down VATS technique utilizes higher intercostal access to provide a comprehensive thoracic view while minimizing diaphragmatic interference. The 180-degree rotated assistant monitor allows both surgeon and assistant to share a thoracotomy-like visual field, enhancing intraoperative coordination. In this case, it facilitated a stable operative field and phrenic nerve preservation despite the tumor's proximity without diaphragmatic interference. The confronting upside-down VATS technique may be particularly advantageous for anterior mediastinal tumors located along the phrenic nerve and in close proximity to the diaphragm.
Journal • Video
|
CD34 (CD34 molecule)
1d
Resveratrol supplementation mitigates age-related declines in egg production, quality, and ovarian health of laying hens. (PubMed, Anim Nutr)
RES also suppressed IL-6, IL-8, TNF-α, and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) expression, and enhanced anti-apoptotic genes B-cell lymphoma-extra-large and B-cell lymphoma 2 expression (P < 0.05). In conclusion, RES supplementation (400 mg/kg) effectively improved laying performance, egg quality, and oxidative and inflammatory responses in laying hens, suggesting its potential as a nutritional strategy to support laying performance during the late production stages.
Journal
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • HMOX1 (Heme Oxygenase 1) • NQO1 (NAD(P)H dehydrogenase, quinone 1)
1d
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo. (PubMed, J Dtsch Dermatol Ges)
CP and CPG patients have an increased lymphoma risk, linked to specific biomarkers, highlighting the importance of increased clinical vigilance in their management.
Journal
|
B2M (Beta-2-microglobulin)
1d
Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders. (PubMed, Pharmacol Res)
Aberrant B cell receptor signaling occurs in several B cell neoplasms including follicular lymphoma (treated with zanubrutinib, a BTK inhibitor), mantle cell lymphoma (acalabrutinib, pirtobrutinib, zanubrutinib), marginal zone lymphoma (zanubrutinib), chronic lymphocytic leukemia and small lymphocytic lymphoma (ibrutinib, acalabrutinib, zanubrutinib, pirtobrutinib), and Waldenström macroglobulinemia (ibrutinib, zanubrutinib)...Pirtobrutinib fails to form a covalent bond and is a reversible BTK inhibitor. The FDA-approvals of rilzabrutinib and remibrutinib (2025) represent the first nononcologic authorizations for BTK antagonists.
FDA event • Review • Journal
|
BTK (Bruton Tyrosine Kinase) • PLCG2 (Phospholipase C Gamma 2) • LYN (LYN Proto-Oncogene Src Family Tyrosine Kinase) • SYK (Spleen tyrosine kinase)
|
Imbruvica (ibrutinib) • imatinib • cyclophosphamide • Brukinsa (zanubrutinib) • Calquence (acalabrutinib) • vincristine • prednisone • Jaypirca (pirtobrutinib) • Rhapsido (remibrutinib)